ヘルスケア株
| # | 過去7日 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4796 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.18 USD | +5.31% | +172.50% | +61.48% | -18.35% | 5.54 M USD | ||
| 4803 |  NVNO enVVeno Medical Corporation - Common Stock | 7.93 USD | +9.53% | -5.71% | -13.71% | +929.87% | 5.41 M USD | ||
| 4804 |  CELZ Creative Medical Technology Holdings, Inc. - Common Stock | 0.82 USD | +6.49% | -4.65% | -4.65% | -79.45% | 5.41 M USD | ||
| 4811 |  CDIO Cardio Diagnostics Holdings Inc. - Common stock | 1.78 USD | +6.59% | -6.32% | -11.00% | -32.06% | 5.27 M USD | ||
| 4813 |  AIM AIM ImmunoTech Inc. Common Stock | 0.17 USD | +6.25% | -5.56% | -19.05% | -93.61% | 5.18 M USD | ||
| 4814 |  NRSN NeuroSense Therapeutics Ltd. - Ordinary Shares | 3.17 USD | +3.59% | -12.19% | -50.08% | +166.39% | 5.16 M USD | ||
| 4815 |  PULM Pulmatrix, Inc. - Common Stock | 1.41 USD | +2.92% | -4.08% | +0.71% | -70.00% | 5.15 M USD | ||
| 4821 |  TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 USD | +19.97% | +23.52% | +13.29% | +685.15% | 4.95 M USD | ||
| 4822 |  LEXX Lexaria Bioscience Corp. - Common Stock | 2.99 USD | +6.03% | -9.67% | -2.61% | +255.95% | 4.94 M USD | ||
| 4829 |  LGVN Longeveron Inc. - Class A Common stock | 1.50 USD | -13.29% | -37.50% | -52.23% | +163.16% | 4.78 M USD | ||
| 4831 |  CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.68 USD | -10.02% | -4.91% | +4.84% | +60.00% | 4.71 M USD | ||
| 4832 |  XTLB XTL Biopharmaceuticals Ltd - American Depositary Shares | 1.99 USD | +5.85% | +0.51% | -15.32% | +121.11% | 4.71 M USD | ||
| 4833 |  PCSA Processa Pharmaceuticals, Inc. - Common Stock | 1.68 USD | +3.70% | +32.28% | -9.19% | -24.32% | 4.69 M USD | ||
| 4835 |  XBIO Xenetic Biosciences, Inc. - Common Stock | 2.00 USD | -4.76% | -9.50% | -11.89% | -53.27% | 4.69 M USD | ||
| 4840 |  QCLS Q/C Technologies, Inc. - Common Stock | 0.56 USD | +3.70% | -11.11% | -29.11% | -89.87% | 4.59 M USD | ||
| 4844 |  CODX Co-Diagnostics, Inc. - Common Stock | 0.72 USD | -5.26% | -33.94% | -26.53% | -77.50% | 4.50 M USD | ||
| 4847 |  INBS Intelligent Bio Solutions Inc. - Common Stock | 1.44 USD | -0.69% | -8.86% | -26.90% | -70.49% | 4.36 M USD | ||
| 4851 |  ITOC iTonic Holdings Ltd - Class A Ordinary Shares | 4.05 USD | +6.58% | -0.98% | +1346.43% | +350.00% | 4.32 M USD | ||
| 4852 |  LIMN Liminatus Pharma, Inc. - Class A Common Stock | 3.21 USD | -1.23% | -9.58% | -4.18% | +163.11% | 4.31 M USD | ||
| 4854 |  NCNA NuCana plc - American Depositary Shares | 1.02 USD | -2.86% | -9.73% | -23.31% | -52.56% | 4.25 M USD |
ニュース ヘルスケア株
UBS、Solid Biosciencesのカバレッジを開始、投資判断は「買い」、目標株価20ドルを発表
MacroGenics、進行固形腫瘍患者を対象とした、非開示標的に向けた抗体薬物複合体MGC030の第1相試験で最初の患者への投与を開始
木曜日の取引中に動いたヘルスケア株12銘柄
Dyadic Internationalの13G提出書類は、Empery Asset Managementが9月30日時点で同社株式8.35%を保有していると報告していることを示す
NeurAxis、医療ポリシーの適用対象が2,600万人超の医療保険加入者に拡大したと発表
Edesa Biotech、尋常性白斑におけるEB06の第2相臨床試験に関する治験薬（IND）申請についてFDAの承認を取得
Wedbush、Sutro Biopharmaの「アウトパフォーム」を再確認、目標株価60ドルを維持
上昇銘柄ヘルスケア株
 ESLA Estrella Immunopharma, Inc. - Common Stock | 0.54 | +68.75% |
 DRMA Dermata Therapeutics, Inc. - Common Stock | 0.91 | +37.88% |
 INDP Indaptus Therapeutics, Inc. - Common Stock | 2.85 | +28.96% |
 HUMA Humacyte, Inc. - Common Stock | 0.44 | +25.71% |
 NMRA Neumora Therapeutics, Inc. - Common Stock | 0.43 | +22.86% |
 PIIIW P3 Health Partners Inc. - Warrant | 0.0072 | +20.00% |
TRIB Trinity Biotech plc - American Depositary Shares each represent | 7.93 | +19.97% |
 AKTX Akari Therapeutics Plc - American Depositary Shares | 8.67 | +19.75% |
下落銘柄ヘルスケア株
 SPRC SciSparc Ltd. - Ordinary Shares | 2.00 | -44.75% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 NXGLW NexGel, Inc - Warrant | 0.0065 | -27.78% |
 DRTSW Alpha Tau Medical Ltd. - Warrant | 2.9900 | -17.40% |
 PFSA Profusa, Inc. - Common Stock | 1.07 | -16.41% |
 MDAIW Spectral AI, Inc. - Warrants | 0.4100 | -16.33% |
 CDTTW CDT Equity Inc. - Warrant | 0.0061 | -15.28% |
 PTN Palatin Technologies, Inc. Common Stock | 6.49 | -15.27% |